Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMZ40RQ)

• Drug Name: Propyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine Drug Info
• Synonyms: CHEMBL80414; 2H-Indazol-5-amine, 4,5,6,7-tetrahydro-N-propyl-; Propyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine; SCHEMBL19048481; BDBM50017539

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID:
  PubChem CID: 14539719
  TTD Drug ID: DMZ40RQ

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Dopamine D2 receptor (D2R)	TTEX248	DRD2_HUMAN	Inhibitor	[1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Dopamine D2 receptor (D2R)	DTT	DRD2	5.345	5.634	5.789	5.901

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Dopamine D2 receptor (D2R)	DTT	DRD2	2.50E-02	-0.08	-0.49

References

• [1] Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity. J Med Chem. 1989 Oct;32(10):2388-96.